SE:ACE Stock Latest News
Company AnnouncementsAscelia Pharma Charts New Path for Orviglance After FDA Meeting3w ago
Company AnnouncementsAscelia Pharma’s Orviglance Study Published in Leading MRI Journal1M ago
Company AnnouncementsAscelia Pharma Holds FDA Type A Meeting on Orviglance NDA1M ago
Company AnnouncementsAscelia Pharma Tightens Costs After FDA Setback on Orviglance2M ago
Company AnnouncementsAscelia Pharma Secures FDA Type A Meeting on Orviglance NDA2M ago
Company AnnouncementsAscelia Pharma Restructures and Cuts Costs to Sharpen Focus on Orviglance3M agoCompany AnnouncementsAscelia Pharma Defends Orviglance Data After FDA Complete Response Letter3M ago
Company AnnouncementsAscelia Pharma Bolsters Orviglance Franchise with New Patent Filing4M ago- Company AnnouncementsAscelia Showcases Orviglance MRI Data at ESGAR 2026 Amid FDA Review4M ago
Company AnnouncementsAscelia Pharma Nears FDA Decision on Orviglance and Bolsters Finances for Partnering Push5M ago
Company AnnouncementsAscelia Pharma AGM Backs Incentive Plan but Rejects Share Issue Mandate6M ago
Company AnnouncementsAscelia Pharma Expands Share Capital After Directed New Issue6M agoCompany AnnouncementsAscelia Pharma Raises SEK 20 Million in Directed Share Issue Ahead of Orviglance Milestone6M ago
Company AnnouncementsAscelia Pharma Calls 2026 AGM, Proposes No Dividend and New Incentive Plan7M ago- Company AnnouncementsAscelia’s Liver Imaging Agent Orviglance Selected for Key ESGAR 2026 Presentation7M ago
Company AnnouncementsAscelia Pharma’s Orviglance NDA Accepted by FDA as Cash Runway Extends Beyond 2026 Decision8M ago- Company AnnouncementsAscelia Pharma Deputy CEO and CFO Julie Waras Brogren to Depart for New CEO Role9M ago
Company AnnouncementsAscelia Pharma Appoints Nomination Committee Ahead of 2026 AGM10M agoCompany AnnouncementsAscelia Pharma Converts Series C Shares to Ordinary Shares for Incentive Program11M ago
